Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor–type integrins inhibits retinal neovascularization (original) (raw)

References

  1. Prost, M. Experimental studies on the pathogensis of retinopathy of prematurity. Br. J. Ophthalmol. 72, 363–367 (1988).
    Article CAS Google Scholar
  2. Thylefors, B., Negrel, A.D., Pararajasegaram, R. & Dadzie, K.Y. Global data on blindness. Bull. World. Health. Organ. 73, 115–121 (1995).
    CAS PubMed PubMed Central Google Scholar
  3. Moss, S.E., Klein, R. & Klein, B.E. Ten-year incidence of visual loss in a diabetic population. Ophthalmology 101, 1061–1070 (1994).
    Article CAS Google Scholar
  4. Brown, G.C., Brown, R.H. & Brown, M.M. Peripheral proliferative retinopathies. Int. Ophthalmol. 11, 41–50 (1987).
    Article CAS Google Scholar
  5. The Diabetic retinopathy Study Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of DRS findings. Ophthalmology 88, 583–600 (1981).
  6. Stone, J. et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J. Neurosci. 15, 4738–4747 (1995).
    Article CAS Google Scholar
  7. Peèr, J. et al. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab. Invest. 72, 638–645 (1995).
    Google Scholar
  8. Bischoff, J. Approaches to studying cell adhesion molecules in angiogenesis. Trends Cell Biol. 5, 69–74 (1995).
    Article CAS Google Scholar
  9. Bacharach, E., Itin, A. & Keshet, E. In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc. Natl. Acad. Sci. USA 89, 10686–10690 (1992).
    Article CAS Google Scholar
  10. Pierce, E.A., Avery, R.L., Foley, E.D., Aiello, L.P. & Smith, L.E.H. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. USA 92, 905–909 (1995).
    Article CAS Google Scholar
  11. Schultz, G.S. & Grant, M.B. Neovascular growth factors. Eye 5, 170–180 (1991).
    Article Google Scholar
  12. Pfeiffer, A. & Schatz, H. Diabetic microvascular complications and growth factors. Exp. Clin. Endocrinol. Diabetes 103, 7–14 (1995).
    Article CAS Google Scholar
  13. Berka, J.L. et al. Renin-containing Mueller cells of the retina display endocrine features. Invest. Ophthalmol. Vis. Sci. 36, 1450–1458 (1995).
    CAS PubMed Google Scholar
  14. Robbins, S.G. et al. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest. Ophthalmol. Vis. Sci. 35, 3649–3663 (1994).
    CAS PubMed Google Scholar
  15. Spranger, J., Meyer-Schwickerath, R., Klein, M., Schatz, H. & Pfeiffer, A. TNF-α level in the vitreous body: Increase in neovascular eye diseases and proliferative diabetic retinopathy. Med. Klin. 90, 134–137 (1995).
    CAS Google Scholar
  16. Leavesley, D.I., Ferguson, G.D., Wayner, E.A. & Cheresh, D.A. Requirement of the integrin β3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen. J. Cell Biol. 117, 1101–1107 (1992).
    Article CAS Google Scholar
  17. Felding-Habermann, B. & Cheresh, D.A. Vitronectin and its receptors. Curt. Opin. Cell Biol. 5, 864–868 (1993).
    Article CAS Google Scholar
  18. Brooks, P.C., Clark, R.A.F. & Cheresh, D.A. Requirement of vascular integrin αvβ3 for angiogenesis. Science 264, 569–571 (1994).
    Article CAS Google Scholar
  19. Casaroli Marano, R.P. & Vilaro, S. The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 35, 2791–2903 (1994).
    CAS PubMed Google Scholar
  20. Casaroli Marano, R.P., Preissner, K.T. & Vilaro, S., Fibronectin, laminin, vitronectin and their receptors at newly-formed capillaries in proliferative diabetic retinopathy. Exp. Eye Res. 60, 5–17 (1995).
    Article CAS Google Scholar
  21. Brooks, P.C. et al. Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157–1164 (1994).
    Article CAS Google Scholar
  22. Friedlander, M. et al. Definition of two angiogenic pathways by distinct αv integrins. Science 270, 1500–1502 (1995).
    Article CAS Google Scholar
  23. Millauer, B., Shawver, L.K., Plate, K.H., Risau, W. & Ullrich, A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367, 576–579 (1994).
    Article CAS Google Scholar
  24. Smith, L.E.H. et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Invest. Ophthalmol. Vis. Sci. 35, 101–111 (1994).
    CAS PubMed Google Scholar
  25. Aumailley, M. et al. Arg-Gly-Asp constrained within cyclic pentapeptides: Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1. FEBS Lett. 291, 50–54 (1991).
    Article CAS Google Scholar
  26. Sasisekharan, R., Moses, M.A., Nugent, M.A., Cooney, C.L. & Langer, R. Heparinase inhibits neovascularization. Proc. Natl. Acad. Sci. USA 91, 1524–1528 (1994).
    Article CAS Google Scholar
  27. Iruela-Arispe, M.L., Bornstein, P. & Sage, H. Thrombospondin exerts an anti-angiogenic effect on cord formation by endothelial cells in vitro. Proc. Natl. Acad. Sci. USA 88, 5026–5030 (1991).
    Article CAS Google Scholar
  28. Dameron, K.M., Volpert, O.V., Tainsky, M.A. & Bouck, N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265, 1582–1584 (1994).
    Article CAS Google Scholar
  29. Moses, M.A., Sudhalter, J. & Langer, R. Identification of an inhibitor of neovascularization from cartilage. Science 248, 1408–1410 (1990).
    Article CAS Google Scholar
  30. Johnson, M.D. et al. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J. Cell. Physiol. 160, 194–202 (1994).
    Article CAS Google Scholar
  31. O'Reilly, M.S. et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315–328 (1994).
    Article CAS Google Scholar
  32. Aiello, L.P. et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 331, 1480–1487 (1994).
    Article CAS Google Scholar
  33. Jonczyk, A. et al. Zyklische Adhäsionsinhibitoren. EP 0 632 053 (1993).
  34. Preissner, K.T., Anders, E., Grulich-Henn, J. & Müller-Berghaus, G. Attachment of cultured human endothelial cells is promoted by specific association with S protein (vitronectin) as well as with the ternary S protein-thrombin-antithrombin III complex. Blood 71, 1581–1589 (1988).
    CAS PubMed Google Scholar

Download references